Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D at hospital admission as an independent predictor of outcome of sepsis patients: Results of a secondary analysis from a "Need-Speed" trial prospective cohort.

European journal of internal medicine·2026
Same author

Macrophage Extracellular Traps in the Oral Mucosa: Autoimmune Disease and Platelet-Derived Epithelial Modulation.

Life (Basel, Switzerland)·2026
Same author

Higher 25(OH)D Levels at Admission Predict a Favorable Disease Evolution in Moderate-to-Severe COVID-19 Patients.

International journal of molecular sciences·2026
Same author

Gut Microbiota as a Key Modulator in the Pathophysiology of Sepsis: SURVEIL Project.

MicrobiologyOpen·2026
Same author

Pore-level quantitative structure-activity relationship (QSAR) for water permeation rate in aquaporins.

Biochimica et biophysica acta. Biomembranes·2026
Same author

Clinical significance of head CT scan in patients admitted to the emergency department with mild head trauma.

Internal and emergency medicine·2026

Related Experiment Video

Updated: Jun 26, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Hyperosmolar coma due to exclusive glucose accumulation: recognition and computations.

Ettore Bartoli1, Pier Paolo Sainaghi, Luca Bergamasco

  • 1Internal Medicine, Department of Clinical and Experimental Medicine, Eastern Piedmont University, Novara, Italy.

Nephrology (Carlton, Vic.)
|January 31, 2009
PubMed
Summary

This study introduces a new model to accurately predict sodium levels during hyperosmolar coma (HC) treatment. The improved estimation helps prevent dangerous electrolyte imbalances in patients undergoing correction.

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Area of Science:

  • Nephrology
  • Endocrinology
  • Internal Medicine

Background:

  • Hyperosmolar coma (HC) treatment requires careful management of electrolytes.
  • Accurate prediction of plasma sodium (PNa) is crucial to avoid complications.
  • Current methods for estimating PNa during HC correction have limitations.

Purpose of the Study:

  • To develop an improved method for predicting plasma sodium (PNa(PREDICTED)) during hyperosmolar coma (HC) correction.
  • To enhance the accuracy of PNa estimation by accounting for glucose addition and water loss.
  • To minimize electrolyte derangements during HC treatment.

Main Methods:

  • Derived new equations to calculate glucose addition (G(A)) and water loss (DeltaV).
  • Utilized computer simulations to test the accuracy of the derived formulas.
  • Validated the model using data from 68 patients with hyperosmolar coma.

Main Results:

  • Computer simulations showed perfect correlation between true and calculated values (R=1).
  • In patient data, the new model accurately predicted PNa(PREDICTED) with high correlation (R(2)=0.99).
  • The method successfully identified and excluded cases with concomitant sodium loss.

Conclusions:

  • The novel model system and formulas significantly improve the accuracy of PNa(PREDICTED) estimation in HC.
  • This enhanced accuracy aids clinicians in preventing electrolyte disturbances during HC treatment.
  • The findings support the clinical utility of the new model for managing HC.